Breast Cancer Exercise Intervention Study (BREXINT)
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a 24-week exercise programme consisting of aerobic exercise and muscle strength training, 3 sessions per week. The first 9 sessions are supervised by physiotherapists in person, followed by 63 sessions monitored remotely (video) or supervised by trainers at ActiveSG (Sport Singapore) gyms.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 21
Maximum Age: 99
Healthy Volunteers: f
View:
• Patients with histologically or cytologically proven stage 1, 2, or 3 breast cancer
• Patients who have undergone curative breast surgery
• Patients who have received (neo)adjuvant chemotherapy (if given) and/or radiotherapy (if given)
• Females aged 21 years and older
• ≤ 8 weeks from breast surgery, or the last adjuvant chemotherapy or radiotherapy session, whichever is latest.
Locations
Other Locations
Singapore
National Cancer Centre
RECRUITING
Singapore
National University Hospital
RECRUITING
Singapore
Singapore General Hospital
RECRUITING
Singapore
Contact Information
Primary
Dr Elaine LIM, MD, PhD
elaine.lim.hsuen@singhealth.com.sg
+65 64368000
Backup
Catherine CELES
catherine.celes@nccs.com.sg
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2033-05-31
Participants
Target number of participants: 2156
Treatments
Experimental: Exercise
The exercise intervention group will undergo an aerobic exercise and strength training programme, comprising 3 sessions per week, spanning 24 weeks (total: 3x24=72 sessions).
Experimental: Control
The usual care group.
Related Therapeutic Areas
Sponsors
Collaborators: Singapore General Hospital, Singapore Cancer Society, Genome Institute of Singapore, National University of Singapore
Leads: National Cancer Centre, Singapore